Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gritstone Oncology Inc (GRTS)
NASDAQ:GRTS
Gritstone Oncology (GRTS) Stock Price & Analysis
523 Followers
GRTS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.14 - $4.05
Previous Close$1.3
Volume1.89M
Average Volume (3M)2.43M
Market Cap
$123.94M
Enterprise Value$135.30M
Total Cash (Recent Filing)$83.95M
Total Debt (Recent Filing)$95.30M
Price to Earnings (P/E)-1.0
Beta1.49
Next Earnings
Mar 07, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.30
Shares Outstanding95,342,055
10 Day Avg. Volume1,326,185
30 Day Avg. Volume2,434,882
Standard Deviation0.52
R-Squared0.00432
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)1.70
Price to Sales (P/S)6.21
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue13.23
Enterprise Value/Gross Profit6.78
Enterprise Value/Ebitda-0.99
Forecast
1Y Price Target
$10.40Price Target Upside579.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Gritstone Oncology News
Ownership Overview
0.00% Insiders
7.83% Mutual Funds
27.38% Other Institutional Investors
64.79% Public Companies and
Individual Investors
GRTS FAQ
What was Gritstone Oncology Inc’s price range in the past 12 months?
Gritstone Oncology Inc lowest stock price was $1.14 and its highest was $4.05 in the past 12 months.
What is Gritstone Oncology Inc’s market cap?
Currently, no data Available
When is Gritstone Oncology Inc’s upcoming earnings report date?
Gritstone Oncology Inc’s upcoming earnings report date is Mar 07, 2024 which is in 96 days.
How were Gritstone Oncology Inc’s earnings last quarter?
Gritstone Oncology Inc released its earnings results on Nov 08, 2023. The company reported -$0.33 earnings per share for the quarter, beating the consensus estimate of -$0.34 by $0.01.
Is Gritstone Oncology Inc overvalued?
According to Wall Street analysts Gritstone Oncology Inc’s price is currently Undervalued.
Does Gritstone Oncology Inc pay dividends?
Gritstone Oncology Inc does not currently pay dividends.
What is Gritstone Oncology Inc’s EPS estimate?
Gritstone Oncology Inc’s EPS estimate is -$0.29.
How many shares outstanding does Gritstone Oncology Inc have?
Gritstone Oncology Inc has 95,342,060 shares outstanding.
What happened to Gritstone Oncology Inc’s price movement after its last earnings report?
Gritstone Oncology Inc reported an EPS of -$0.33 in its last earnings report, beating expectations of -$0.34. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of Gritstone Oncology Inc?
Among the largest hedge funds holding Gritstone Oncology Inc’s share is Versant Venture Management, LLC. It holds Gritstone Oncology Inc’s shares valued at 6M.
---
Gritstone Oncology Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.40 (579.74% Upside)
$10.40 (579.74% Upside)
Blogger Sentiment
Bullish
GRTS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 63.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.78%
12-Months-Change
Fundamentals
Return on Equity
-131.82%
Trailing 12-Months
Asset Growth
-8.78%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Gritstone Oncology Inc
Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded in August 2015 by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria and is headquartered in Emeryville, CA.
---
Top 5 ETFs holding GRTS
Vanguard Total Stock Market ETF
$5.01M
Vanguard Russell 3000 ETF
$10.44K
Up to five ETFs with an Outperform Smart Score that hold GRTS. The ETFs are listed according to market value of GRTS within the ETF
---